Latest industry research report on Stereotactic surgery is a procedure used to perform the actions such as ablation, biopsy, lesion, injection, stimulation, implantation and radiosurgery. It is a minimally invasive technique, which uses a coordinate system to locate small targets inside the body. The increasing demand of minimally invasive techniques, increasing replacement of levodopa therapy by stereotactic surgery and increasing incidences of brain tumors, Parkinsons disease and epilepsy are driving the growth of stereotactic surgery devices market. Furthermore, the absence of alternative treatment has increased the demand for stereotactic surgery devices.
Get Free Sample Report Of Stereotactic surgery Market @ http://www.marketresearchstore.com/report/world-stereotactic-surgery-devices-market-opportunities-and-71720#RequestSample
Factors restraining the market growth are high initial setup cost and presence of stringent regulatory environment.
Few strategies adopted by major market players are collaboration and product launch. For Instance, BrainLAB and the UZ Brussel collaborated to conduct the Novalis Body project and Integra Neurosciences launched CRW biopsy plus kit. The companies profiled in this report are Inomed, Monteris Medical, Alliance Oncology, Elekta AB, adeor Medical AG, Micromar, Modus Medical Devices, Raysearch Laboratories, IBA Proton therapy and CIRS.
The stereotactic surgery devices market is segmented as below:
Stereotactic Surgery Devices Market By Equipment Type
- The gamma knife
- Line accelerator (LINAC) machines
- Proton beam
Do Inquiry To Buy Report Of Stereotactic surgery Market @ http://www.marketresearchstore.com/report/world-stereotactic-surgery-devices-market-opportunities-and-71720#InquiryForBuying
Stereotactic Surgery Devices Market By Applications
- Brain tumor treatment
- Arteriovenous malformations treatment
- Parkinsons disease
- Others (trigeminal neuralgia)